「够稳」和「够灵」可以是反向的:φ-SD 够不够格当协调稳定性终点,取决于它的 ICC 高在哪一半

Written by

in

Language

Evidence level: C

判断一个指标能不能当终点,不该只问它「稳不稳」,而要问它稳在哪一半——是测量精度撑起来的稳,还是样本里人跟人差得远撑起来的稳。前者是资格,后者是幻觉。而这两件事,靠同一个 ICC 数字根本分不开。

一、先把一个判决拆成两个

「φ-SD 够不够格当协调稳定性终点」这句话里,其实压着两条互不等价的判决:一是它测得准不准,二是它动不动。临床测量学把这两件事分得很清楚——一个量表可以稳定得无可挑剔,却对任何干预都不动分毫。把「稳」当作唯一资格线,选出来的可能是一个稳得像块石头、因此什么都测不到的指标。所以这一节先把判决拆成两条:信度(重复测量是否一致)与反应性(真实变化能否被照出来)。后面五节分别看这两条线各自会怎么坑人,以及它们为什么会一起坑人。

二、ICC 是比率,分子是「人和人差多少」

ICC 的算法是「个体间方差 ÷(个体间方差 + 误差方差)」。分子的名字叫个体间方差,实际含义是采样人群有多杂,不是测量有多准。481 项影像组学研究的系统综述把这条说透了:高 ICC 可能主要反映样本里个体差异大(比如恶性肿瘤),并不保证量化精准;反过来,在同样精准的测量下,同质样本(如正常组织)会给出低 ICC(PMID 34603997)。这对 φ-SD 是直接的:只招新手,个体差异本来就窄,ICC 被压到不合格;混招新手与老手,ICC 被抬到合格。同一台带子、同一套算法,资格结论由抽样决定。ICC 估错的代价也有硬账——某研究按文献 ICC=0.02 规划样本,实测 0.12–0.17,有效样本缩水 17 倍(PMID 20167897)。

三、同一件事,两篇论文给出相反结论

信度能不能替代反应性,文献本身是打起来的。一派把量表逐项拆解,发现内部一致性系数与标准化反应均值(SRM)的相关高达 0.90–1.00,结论是两者可互换(PMID 15691385)。另一派在 516 名慢阻肺与膝损伤患者、79 个量表域上重做,得到的相关只有 0.10(95%CI −0.12–0.32),并指出前者的做法只在一个量表内部拆项,天然会看到同步下降;他们举出反例:SF-36 躯体疼痛 α=0.93,SRM 只有 0.29(PMID 15877824)。这场争论对本文的意义不是谁对,而是:任何人都不能仅凭信度高就宣布某指标够格当终点,尤其在跨组、跨条件比较时。φ-SD 恰好要跨的正是「修炼者 vs 新手」这种组。

四、MDC 与 MID 是两条线,交叉才叫能测

最小可检测变化(MDC)回答「多大变化超出噪声」,最小重要差异(MID)回答「多大变化才有意义」。前者由测量误差算出:MDC=1.96×√2×SEM;后者要靠外部锚定(PMID 16925807)。两者不能互相顶替——有研究直接测过:MDC 无法可靠替代 MID(PMID 19800198)。而现实里最常见的失败形态是 MDC 比 MID 还大:某工作功能量表 SDC 为 7.2–17 分,14 个 MIC 值里只有 1 个超过 SDC,换成高基线亚组则有 10 个超过(PMID 22974498)。翻成直白的话:这个量表在大多数人身上根本测不出「有意义的变化」。φ-SD 若走上同一条路,结局就是课题做完拿不到结论,而不是拿到否定结论。

五、φ-SD 自己的麻烦:离散度的噪声底本来就厚

φ-SD 还有个别人没有的额外负担:它本身是个离散度统计量,其误差同时被相位均值与呼吸次数推着走(跨零与样本量对圆形统计的偏差,已在别篇拆过)。承重的事实是:呼吸模式测量的信度报告极不统一,绝对容积随校准与体位漂移(PMID 42862511);分区贡献的重测信度虽高,却只在运动态验证过(PMID 35226168);而呼吸变异的时间结构(lag-1 自相关、谱斜率)重测性高,复杂的 ARFIMA 长记忆成分却很差(PMID 36618326)。这三条摆在一起指向一个具体处方:如果 φ-SD 不合格,别急着重招人,先试「换形态」——用变异的时间结构代替变异的大小。

六、补救路径:平均 k 次抬得动信度,抬不动反应性

信度是可以买来的。Spearman-Brown 预言公式给出:把 k 次测量取平均,ICC 从 ρ 抬到 kρ/[1+(k−1)ρ](PMID 28342902)。ρ=0.5 时 k=3 抬到 0.75,k=5 抬到 0.83。这条公式好用,但只作用于误差方差那一半,对「分子不够大」毫无办法——同质样本里平均一百次,ICC 照样低。更要紧的是它完全不碰反应性:反应性取决于干预打没打在指标敏感的那一段上,跟测量重复几次无关(PMID 15877824)。所以补救只能救「测不准」,救不了「测不到」。这一条要写进设计里,否则会变成用增加测量次数掩盖指标选错。

七、判据与测法

三格判据,前两格看信度、第三格看反应性:(一)ICC 高但 MDC95 大于可得组间差——不是好指标,是「稳而无用」,终点须换;(二)ICC 高且 MDC95 小于组间差的一半——够格,但必须同时报出抽样异质性(受试者年限跨度、φ-SD 的个体间 SD),否则 ICC 无法解释;(三)ICC 中等(0.5–0.75)——只能做组均值比较,四格判据里的「个体归类」全部降级。测法:≥40 人(刻意含新手与资深两档并分层报 ICC)、同体位、隔日×3 与隔周×2 共 5 次、每次≥10 分钟;同时算 φ-SD 与时间结构指标(lag-1 自相关、谱斜率)两套;另设一次已知能改变胸腹协调的呼吸训练作为反应性探针(效应量参照 PMID 25590447),看 φ-SD 是否真的动。判据里 0.75 与「一半」这两个数没有出处,须由本队列自己的 MID 反解替换。

证据与局限

已验证:ICC 会被样本异质性抬高、且高 ICC 不等于高精度(PMID 34603997,481 项研究系统综述);ICC 估错可使有效样本缩水一个数量级(PMID 20167897,实测);MDC 无法可靠替代 MID(PMID 19800198);MDC 大于 MID 导致「测不出有意义变化」的实证存在(PMID 22974498);平均 k 次测量提升信度的公式成立(PMID 28342902)。

部分验证:信度与反应性的关系在文献中相互矛盾——一派报相关 0.90–1.00(PMID 15691385),一派报 0.10(PMID 15877824)。此处按冲突双方并列,不取单边结论。呼吸模式测量的信度报告不统一、φ 类参数日间稳定性差,属邻近证据外推(PMID 42862511、35226168、36618326),不是 φ-SD 自身的实测值。

待验证:φ-SD 的 ICC、SEM、MDC95 至今无人测过;「φ-SD 对呼吸训练有反应」只是设计假设,未验证;0.75 门槛与「MDC95 < 组间差一半」两条线是借用通例,本领域无出处;若 φ-SD 的个体间方差主要来自年龄与体型而非「协调能力」,则第二格判据失效。

相关阅读

证据等级: C
参考文献: PMID 34603997, PMID 20167897, PMID 15691385, PMID 15877824, PMID 16925807, PMID 19800198, PMID 22974498, PMID 42862511, PMID 35226168, PMID 36618326, PMID 28342902, PMID 25590447

L1 网络状态:该主题尚未进入 L1 对应网络。CORRESPONDENCE_NETWORK.md 中「信度 / 重测 / 最小可检测 / MDC / ICC / 终点 / 离散度 / 标准差 / SD / 胸腹 / 稳定性 / 组内 / 气功 / 最小可检测」14 词全份检索均为 0 命中,仅「相位 / 节律」作为物理侧节点名、「呼吸率 / 呼吸模式」作为生理侧节点名各出现 1 次(备注仅「与节律耦合最直接」);边表止于 E-050(六十甲子纳音↔频率,状态 open,证据栏原文「尚无任何可测来源」)。故本文证据等级封顶 C,不作机制性断言。

证据等级:A=有PubMed直接支撑,B=科学类比/间接证据,C=传统文化共识/初步探索


免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。

\”Stable enough\” and \”responsive enough\” can be inversely related: whether φ-SD qualifies as the endpoint for coordination stability depends on which half of its ICC is high.

Evidence level: C

Determining whether an indicator qualifies as an endpoint should not ask only “Is it stable?” but rather “Stable in which half?”—is the stability supported by measurement precision or by large differences between individuals in the sample? The former constitutes qualification; the latter constitutes illusion. And these two matters cannot be distinguished by the same ICC number alone.

I. Splitting One Judgment into Two

The statement “Is φ-SD qualified to serve as a coordination stability endpoint” actually compresses two non-equivalent judgments: first, whether it measures accurately, and second, whether it responds. Clinical measurement science distinguishes these two matters clearly—a scale can be stable beyond reproach yet remain unresponsive to any intervention whatsoever. Treating “stability” as the sole qualification criterion may select an indicator that is stable like a stone and therefore measures nothing. Thus, this section splits the judgment into two: reliability (consistency across repeated measurements) and responsiveness (ability to reflect true change). The following five sections examine how each of these lines can lead us astray individually, and why they jointly lead us astray.

II. ICC Is a Ratio; the Numerator Reflects “How Much People Differ”

The ICC algorithm is “between-subject variance ÷ (between-subject variance + error variance).” The name of the numerator, between-subject variance, actually signifies how heterogeneous the sampled population is, not how precise the measurement is. A systematic review of 481 imaging radiomics studies clarifies this point: a high ICC may primarily reflect large individual differences within the sample (e.g., malignant tumors), without guaranteeing quantitative precision; conversely, under equally precise measurement conditions, homogeneous samples (e.g., normal tissue) yield a low ICC (PMID 34603997). For φ-SD, this is direct: recruiting only novices, whose individual differences are inherently narrow, depresses the ICC to an unqualified level; mixing novices and experts lifts the ICC to a qualified level. With the same tape and the same algorithm, the qualification conclusion is determined by sampling. The cost of misestimating ICC also has hard accounting—some studies planned samples based on literature ICC=0.02 but observed 0.12–0.17, resulting in an effective sample shrinkage of 17-fold (PMID 20167897).

III. On the Same Matter, Two Papers Give Opposite Conclusions

Whether reliability can substitute for responsiveness is itself contested in the literature. One camp decomposes scales item-by-item and finds that the correlation between internal consistency coefficient and standardized response mean (SRM) reaches 0.90–1.00, concluding that the two are interchangeable (PMID 15691385). Another camp retests across 516 patients with COPD and knee injury on 79 scale domains, obtaining a correlation of only 0.10 (95%CI −0.12–0.32), and points out that the former approach decomposes items only within a single scale, naturally yielding synchronized declines; they offer counterexamples: SF-36 bodily pain α=0.93 but SRM only 0.29 (PMID 15877824). The significance of this debate for our work is not which side is right, but that no one can declare an indicator qualified as an endpoint solely on the basis of high reliability, especially when comparing across groups and conditions. φ-SD precisely must cross the “practitioners vs. novices” group boundary.

IV. MDC and MID Are Two Lines; Crossing Them Means It Can Be Measured

The minimum detectable change (MDC) answers “How large a change exceeds noise,” while the minimum important difference (MID) answers “How large a change is meaningful.” The former is calculated from measurement error: MDC=1.96×√2×SEM; the latter relies on external anchoring (PMID 16925807). The two cannot substitute for each other—studies have directly tested this: MDC cannot reliably replace MID (PMID 19800198). The most common failure mode in reality is when MDC exceeds MID: for one work function scale, SDC ranges 7.2–17 points, and among 14 MIC values, only 1 exceeds SDC, whereas in a high-baseline subgroup, 10 exceed it (PMID 22974498). In plain terms: this scale fundamentally cannot detect “meaningful change” in most people. If φ-SD follows the same path, the outcome is that the study ends without a conclusion rather than with a negative conclusion.

V. φ-SD’s Own Trouble: Its Noise Floor Is Already Thick

φ-SD carries an additional burden not shared by other indicators: it is itself a dispersion statistic, whose error is simultaneously pushed by phase mean and breathing count (cross-zero bias and sample size bias in circular statistics, already dissected elsewhere). The bearing facts are: breathing pattern measurement reliability reports are highly inconsistent; absolute volume drifts with calibration and posture (PMID 42862511); retest reliability of partition contributions is high but verified only in motion (PMID 35226168); while the temporal structure of breathing variation (lag-1 autocorrelation, spectral slope) shows high retestability, complex ARFIMA long-memory components perform poorly (PMID 36618326). These three facts together point to a specific prescription: if φ-SD fails qualification, do not rush to recruit more people; instead try “changing form”—using variation in temporal structure rather than variation in magnitude.

VI. Remediation Path: Averaging k Measurements Can Lift Reliability, Not Responsiveness

Reliability can be bought. The Spearman-Brown prophecy formula gives: averaging k measurements lifts ICC from ρ to kρ/[1+(k−1)ρ] (PMID 28342902). When ρ=0.5, k=3 lifts it to 0.75, k=5 lifts it to 0.83. This formula is useful but acts only on the error-variance half, leaving “numerator not large enough” completely unsolved—even averaging 100 times in homogeneous samples still yields low ICC. More critically, it does not touch responsiveness at all: responsiveness depends on whether the intervention hits the sensitive segment of the indicator, regardless of how many times it is measured (PMID 15877824). Thus, remediation can only save “cannot measure accurately,” not “cannot measure at all.” This must be written into the design, otherwise it becomes masking indicator selection errors by increasing measurement repetitions.

VII. Criteria and Measurement Methods

Three-grid criteria, with the first two grids examining reliability and the third grid examining responsiveness: (I) ICC is high but MDC95 exceeds available between-group differences—not a good indicator, it is “stable yet useless”; the endpoint must be changed; (II) ICC is high and MDC95 is less than half the between-group difference—qualified, but must simultaneously report sampling heterogeneity (subject age span, φ-SD between-subject SD), otherwise ICC cannot be explained; (III) ICC is moderate (0.5–0.75)—only suitable for group mean comparison; all “individual classification” items in the four-grid criterion must be downgraded. Measurement method: ≥40 participants (deliberately including both novice and expert tiers, reporting ICC stratified), same posture, 3 days apart ×3 and 1 week apart ×2 totaling 5 times, each ≥10 minutes; simultaneously calculate φ-SD and temporal structure indicators (lag-1 autocorrelation, spectral slope) in two sets; additionally set up one breathing training known to alter thoraco-abdominal coordination as a responsiveness probe (effect size referenced PMID 25590447), to see whether φ-SD truly moves. The numbers 0.75 and “half” in the criteria have no source; they must be replaced by back-solving from this cohort’s own MID.

Evidence and Limitations

Verified: ICC is elevated by sample heterogeneity, and high ICC does not equal high precision (PMID 34603997, systematic review of 481 studies); misestimating ICC can shrink effective sample by an order of magnitude (PMID 20167897, observed); MDC cannot reliably replace MID (PMID 19800198); empirical evidence exists that MDC > MID leads to “cannot detect meaningful change” (PMID 22974498); the formula for averaging k measurements to improve reliability holds (PMID 28342902).

Partially Verified: The relationship between reliability and responsiveness is contradictory in the literature—one camp reports correlation 0.90–1.00 (PMID 15691385), another reports 0.10 (PMID 15877824). Here both conflicting sides are listed side-by-side, without taking a unilateral conclusion. Breathing pattern measurement reliability reports are inconsistent; φ-type parameters show poor day-to-day stability, constituting extrapolation beyond proximal evidence (PMID 42862511, 35226168, 36618326), not φ-SD’s own measured values.

To Be Verified: φ-SD’s ICC, SEM, MDC95 have never been measured; “φ-SD responds to breathing training” is only a design hypothesis, unverified; the 0.75 threshold and “MDC95 < half of between-group difference” are borrowed from convention, with no source in this field; if φ-SD’s between-subject variance stems primarily from age and body size rather than “coordination ability,” then the second-grid criterion fails.

Related Reading

Evidence Level: C
References: PMID 34603997, PMID 20167897, PMID 15691385, PMID 15877824, PMID 16925807, PMID 19800198, PMID 22974498, PMID 42862511, PMID 35226168, PMID 36618326, PMID 28342902, PMID 25590447

L1 Network Status: This topic has not yet entered the L1 corresponding network. In CORRESPONDENCE_NETWORK.md, all 14 terms—”reliability / retest / minimum detectable / MDC / ICC / endpoint / dispersion / standard deviation / SD / thoraco-abdominal / stability / within-group / qigong / minimum detectable”—have zero hits; only “phase / rhythm” appears once as a physical-side node name, and “breathing rate / breathing pattern” appears once as a physiological-side node name (note: only “most directly coupled with rhythm”); edge table stops at E-050 (Sixty Jiazi Yin-Yang ↔ Frequency, status open, evidence column original text “no measurable source yet“). Therefore, this article’s evidence level caps at C, making no mechanistic assertions.


Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *